Fatigue in Cardiopulmonary Disease

Physical Medicine and Rehabilitation Clinics of North America

Volumn 20, Issue 2, 2009, Pages 389-404

  Bartels, Matthew N ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Cardiac disease; Cardiac rehabilitation; Exercise; Fatigue; Pulmonary disease; Pulmonary rehabilitation

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; INTERFERON; PREDNISONE; TACROLIMUS;

ANXIETY; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COLLAGEN DISEASE; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MEGADOSE; EXERCISE; FATIGUE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KINESIOTHERAPY; LUNG DISEASE; MYOPATHY; OBESITY; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; VASCULAR DISEASE;

DISABILITY EVALUATION; FATIGUE; HEART DISEASES; HUMANS; INCIDENCE; LUNG DISEASES; UNITED STATES;

EID: 64749083785     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2008.12.002     Document Type: Review

References (58)

1. Anderson H., Ward C., Eardley A., et al. The concerns of patients under palliative care and a heart failure clinic are not being met. Palliat Med 15 (2001) 279-286
2. Lynn J., Teno J.M., Phillips R.S., et al. Perceptions by family members of the dying experience of older and seriously ill patients. Ann Intern Med 126 2 (1997) 97-106
3. Nordgren L., and Sorensen S. Symptoms experienced in the last six months of life in patients with end-stage heart failure. Eur J Cardiovasc Nurs 2 3 (2003) 213-217
4. Skilbeck J., Mott L., Page H., et al. Palliative care in chronic obstructive airways disease: a needs assessment. Palliat Med 12 (1998) 245-254
5. Milner K.A., Funk M., Richards S., et al. Gender differences in symptom presentation associated with coronary heart disease. Am J Cardiol 84 (1999) 396-399
6. Meshack A.F., Goff D.C., and Chan W. Comparison of reported symptoms of acute myocardial infarction in Mexican Americans versus non-Hispanic whites (the Corpus Christi Heart Project). Am J Cardiol 82 (1998) 1329-1332
7. Patel H., Rosengren A., and Ekman I. Symptoms in acute coronary syndromes: does sex make a difference?. Am Heart J 148 1 (2004) 27-33
8. Azevedo A., Bettencourt P., Pimenta J., et al. Clinical syndrome suggestive of heart failure is frequently attributable to non-cardiac disorders - population-based study. Eur J Heart Fail 9 (2007) 391-396
9. Anda R., Williamson D., Jones D., et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 4 (1993) 285-294
10. Barefoot J.C., and Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 93 (1996) 1976-1980
11. Everson S.A., Goldberg D.E., Kaplan G.A., et al. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 58 (1996) 113-121
12. Grippo A.J., and Johnson A.K. Biological mechanisms in the relationship between depression and heart disease. Neurosci Biobehav Rev 26 (2002) 941-962
13. Carney R.M., Saunders R.D., Freedland K.E., et al. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 76 (1995) 562-564
14. Pitzalis M.V., Iacoviello M., Todarello O., et al. Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. Am Heart J 141 (2001) 765-771
15. Rechlin T., Weis M., and Claus D. Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic function. Pharmacopsychiatry 27 (1994) 124-128
16. Rechlin T., Weis M., Spitzer A., et al. Are affective disorders associated with alterations of heart rate variability?. J Affect Disord 32 (1994) 271-275
17. Watkins L.L., and Grossman P. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J 137 (1999) 453-457
18. Spriggs D.R., Sherman M.L., Michie H., et al. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase 1 and pharmacology study. J Natl Cancer Inst 80 (1988) 1039-1044
19. Niiranen A., Laaksonen R., Iivanainen M., et al. Behavioral assessment of patients treated with alpha-interferon. Acta Psychiatr Scand 78 (1988) 622-626
20. Hennein H.A., Ebba H., Rodriguez J.L., et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108 (1994) 626-635
21. Levine B., Kalman J., Mayer L., et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241 [Neurosci 1992;14:1-10]
22. Ter Horst G.J. TNF-alpha-induced selective cerebral endothelial leakage and increased mortality risk in postmyocardial infarction depression. Am J Physiol Heart Circ Physiol 275 (1998) H1910-H1911
23. Ter Horst G.J. Central autonomic control of the heart, angina, and pathogenic mechanisms of post-myocardial infarction depression. Eur J Morphol 37 (1999) 257-266
24. Prescott E., Holst C., Grønbæk M., et al. Vital exhaustion as a risk factor for ischaemic heart disease and all-cause mortality in a community sample. A prospective study of 4084 men and 5479 women in the Copenhagen City Heart Study. Int J Epidemiol 32 (2003) 990-997
25. Kop W.J., Appels A., Mendes de Leon C.F., et al. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med 56 (1994) 281-287
26. Swigris J.J., Kuschner W.G., Jacobs S.S., et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 60 7 (2005) 588-594
27. Trendall J., and Esmond G. Fatigue in people with chronic obstructive pulmonary disease: development of an assessment tool. J Clin Nurs 16 (2007) 116-122
28. Franssen F.M., Wouters E.F., and Schols A.M. The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases. Clin Nutr 21 1 (2002) 1-14
29. Seamark D.A., Seamark C.J., and Halpin D.M. Palliative care in chronic obstructive pulmonary disease: a review for clinicians. J R Soc Med 100 5 (2007) 225-233
30. Wouters E.F. Management of severe COPD. Lancet 364 (2004) 883-895
31. Hong S., and Dimsdale J.E. Physical activity and perception of energy and fatigue in obstructive sleep apnea. Med Sci Sports Exerc 35 7 (2003) 1088-1092
32. Aguillard R.N., Riedel B.W., Lichstein K.L., et al. Daytime functioning in obstructive sleep apnea patients: exercise tolerance, subjective fatigue, and sleepiness. Appl Psychophysiol Biofeedback 23 (1998) 207-217
33. Bardwell W.A., Moore P., Ancoli-Israel S., et al. Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity?. Am J Psychiatry 160 (2003) 350-355
34. Prakash U.B. Lungs in mixed connective tissue disease. J Thorac Imaging 7 2 (1992) 55-61
35. Bartels M.N., and Mattera D. Pulmonary Complications of Cancer and its Treatment. In: Stubblefield M., and O'Dell M. (Eds). Principles and Practices of Cancer Rehabilitation. Chapter 26 (2009), Demos Medical Publishing, New York 331-348
36. Ko D.T., Hebert P.R., Coffey C.S., et al. Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. Arch Intern Med 164 (2004) 1389-1394
37. Ko D.T., Hebert P.R., Coffey C.S., et al. Beta- blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288 (2002) 351-357
38. Bartels M.N., Whiteson J.H., Alba A.S., et al. Cardiopulmonary rehabilitation and cancer rehabilitation. 1. Cardiac rehabilitation review. Arch Phys Med Rehabil 87 3 Suppl (2006) 46-56
39. Sakuma K., Akiho M., Nakashima H., et al. Cyclosporin A modulates cellular localization of MEF2C protein and blocks fiber hypertrophy in the overloaded soleus muscle of mice. Acta Neuropathol 115 6 (2008) 663-674
40. Miyabara E.H., Aoki M.S., and Moriscot A.S. Cyclosporin A preferentially attenuates skeletal slow-twitch muscle regeneration. Braz J Med Biol Res 38 4 (2005) 559-563
41. Terada S., Nakagawa H., Nakamura Y., et al. Calcineurin is not involved in some mitochondrial enzyme adaptations to endurance exercise training in rat skeletal muscle. Eur J Appl Physiol 90 1-2 (2003) 210-217
42. Schmid H., Schmitt H., Eissele R., et al. Nephrotoxicity of cyclosporine A in the rat. Ren Physiol Biochem 16 (1993) 146-155
43. Breil M., and Chariot P. Muscle disorders associated with cyclosporine treatment. Muscle Nerve 22 12 (1999) 1631-1636
44. Killian K.J., LeBlanc P., Martin D.H., et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with airflow limitation. Am Rev Respir Dis 146 (1992) 935-940
45. Mador M.J., Kufel T.J., and Piineda L. Quadriceps fatigue following cycle exercise in patients with COPD. Am J Respir Crit Care Med 161 (2000) 447-453
46. Bartels M.N., Kim H., Whiteson J.H., et al. Pulmonary rehabilitation in patients undergoing lung-volume reduction surgery. Arch Phys Med Rehabil 87 3 Suppl (2006) 84-88
47. Bartels M.N. Rehabilitation management of lung volume reduction surgery. In: Ginsburg M. (Ed). Lung volume reduction surgery (2001), Mosby-Year Book, Inc, St Louis (MO) 97-124
48. Lederer D.J., Thomashow B.M., Ginsburg M.E., et al. Lung-volume reduction surgery for pulmonary emphysema: Improvement in body mass index, airflow obstruction, dyspnea, and exercise capacity index after 1 year. J Thorac Cardiovasc Surg 133 6 (2007) 1434-1438
49. Ries A.L., Make B.J., Lee S.M., et al., National Emphysema Treatment Trial Research Group. The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest 128 6 (2005) 3799-3809
50. King A.C., Haskell W.L., Taylor C.B., et al. Group vs. home-based exercise training in healthy older men and women. JAMA 266 (1991) 1535-1542
51. Franklin B.A., Gordon S., and Timmis G.C. Amount of exercise necessary for the patient with coronary artery disease. Am J Cardiol 69 (1992) 1426-1432
52. Pate R.R., Pratt M., Blair S.N., et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273 (1995) 402-407
53. DeBusk R.F., Stenestrand U., Sheehan M., et al. Training effects of long versus short bouts of exercise in healthy subjects. Am J Cardiol 65 (1990) 1010-1013
54. Franklin B.A., Vander L., Wrisley D., et al. Training ability of arms versus legs in men with previous myocardial infarction. Chest 105 (1994) 262-264
55. Bartels M.N. The role of pulmonary rehabilitation for patients undergoing lung volume reduction surgery. Minerva Pneumologica. Invited Review. Special issue distributed at the Congress of the Italian Society of Respiratory Medicine (Florence, October 4-7). Minerva Pneumol 45 (2006) 177-196
56. Alba A.S., Kim H., Whiteson J.H., et al. Cardiopulmonary rehabilitation and cancer rehabilitation. 2. Pulmonary rehabilitation review. Arch Phys Med Rehabil 87 3 Suppl (2006) 57-64
57. Franklin B.A. Motivating patients to exercise: strategies to increase compliance. Sports Med Digest 16 (1994) 1-3
58. American College of Sports Medicine. In: Durstine J.L., Bloomquist L.E., Figoni S.F., et al. (Eds). ACSM's exercise management for persons with chronic disease and disabilities. 1st edition (1997), Human Kinetics, Champaign (IL)